- Home
- MPWR vs EW Comparison
MPWR vs EW Comparison
Compare MPWR & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPWR
- EW
- Stock Information
- Founded
- MPWR 1997
- EW 1958
- Country
- MPWR United States
- EW United States
- Employees
- MPWR N/A
- EW N/A
- Industry
- MPWR Semiconductors
- EW Industrial Specialties
- Sector
- MPWR Technology
- EW Health Care
- Exchange
- MPWR Nasdaq
- EW Nasdaq
- Market Cap
- MPWR 45.9B
- EW 45.5B
- IPO Year
- MPWR 2004
- EW 2000
- Fundamental
- Price
- MPWR $878.87
- EW $85.12
- Analyst Decision
- MPWR Buy
- EW Buy
- Analyst Count
- MPWR 14
- EW 19
- Target Price
- MPWR $994.29
- EW $92.35
- AVG Volume (30 Days)
- MPWR 771.1K
- EW 5.1M
- Earning Date
- MPWR 10-30-2025
- EW 10-30-2025
- Dividend Yield
- MPWR 0.72%
- EW N/A
- EPS Growth
- MPWR 343.79
- EW N/A
- EPS
- MPWR 39.37
- EW 2.33
- Revenue
- MPWR $2,660,969,000.00
- EW $5,883,800,000.00
- Revenue This Year
- MPWR $28.31
- EW $13.96
- Revenue Next Year
- MPWR $16.81
- EW $9.81
- P/E Ratio
- MPWR $22.16
- EW $37.24
- Revenue Growth
- MPWR 30.48
- EW 10.60
- 52 Week Low
- MPWR $438.86
- EW $65.94
- 52 Week High
- MPWR $1,123.38
- EW $87.21
- Technical
- Relative Strength Index (RSI)
- MPWR 39.54
- EW 60.54
- Support Level
- MPWR $852.04
- EW $83.32
- Resistance Level
- MPWR $917.44
- EW $86.86
- Average True Range (ATR)
- MPWR 44.95
- EW 1.83
- MACD
- MPWR -15.35
- EW -0.14
- Stochastic Oscillator
- MPWR 25.28
- EW 62.56
About MPWR Monolithic Power Systems Inc.
Monolithic Power Systems is an analog and mixed-signal chipmaker specializing in power management solutions. Its mission is to reduce total energy consumption in end systems. It serves the computing, automotive, industrial, communications, and consumer end markets. MPS uses a fabless manufacturing model, partnering with third-party chip foundries to host its proprietary BCD process technology.
About EW Edwards Lifesciences Corporation
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.